Gene-editing approaches are often better suited for autosomal dominant retinal diseases than gene replacement therapies

News | Microperimetry Emerging as a Valuable Tool in Measuring Treatment Efficacy in Clinical Trials

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.